Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Microarray analysis of gene expression mirrors the biology of an ovarian cancer model

Abstract

We have previously described an ovarian cancer model based on four independent spontaneously immortalized epithelial ovarian cancer cell lines (TOV-21G, TOV-81D, TOV-112D and OV-90) from patients who were never exposed to chemotherapy or radiation therapy. These cell lines are particularly interesting since they retain characteristics of the original epithelial ovarian cancers (EOC) from which they were derived. Here we report the characterization of this model system using high-density DNA microarrays in order to assess gene expression. Expression profiles were generated from total RNAs extracted from the four EOC cell lines. For comparison, expression profiling is also provided for a primary culture of normal ovarian surface epithelium (NOV-31) and a fresh EOC sample (TOV-578G). Comparison of expression profiles revealed patterns of expression that distinguish NOV-31 from that of all tumor derived samples. The expression pattern of TOV-81D, an EOC cell line that was derived from a patient with indolent disease, most closely resembles NOV-31 while profiles of samples derived from patients with more aggressive disease (TOV-21G, OV-90, TOV-112D and TOV-578G) showed more divergent patterns of expression. The microarray analysis (http://genome.mcgill.ca) results confirm the usefulness of an ovarian cancer model based on the characterization of these EOC cell lines.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Alama A, Barbieri F, Favre A, Cagnoli M, Noviello E, Pedulla F, Viale M, Foglia G, Ragni N . 1996 Gynecol. Oncol. 62: 82–88

  • Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson Jr J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Staudt LM et al. 2000 Nature 403: 503–511

  • Anttila MA, Kosma VM, Hongxiu J, Puolakka J, Juhola M, Saarikoski S, Syrjanen K . 1999 Br. J. Cancer 79: 1870–1878

  • Asschert JG, Vellenga E, Hollema H, van der Zee AG, de Vries EG . 1997 Eur. J. Cancer 33: 2246–2251

  • Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC . 2001 Endocr. Rev. 22: 255–288

  • Barboule N, Baldin V, Ozan SJ, Vidal S, Valette A . 1998 Int. J. Cancer 76: 891–896

  • Bast Jr RC, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC . 1981 J. Clin. Invest. 68: 1331–1337

  • Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben-Dor A, Sampas N, Dougherty E, Wang E, Marincola F, Gooden C, Lueders J, Glatfelter A, Pollock P, Carpten J, Gillanders E, Leja D, Dietrich K, Beaudry C, Berens M, Alberts D, Sondak V . 2000 Nature 406: 536–540

  • Brown TJ, Shaw PA, Karp X, Huynh MH, Begley H, Ringuette MJ . 1999 Gynecol. Oncol. 75: 25–33

  • Buick RN, Pullano R, Trent JM . 1985 Cancer Res. 45: 3668–3676

  • Buller RE, Niemann T, Connor JP, Squatrito RC, Skilling JS, Anderson B . 1995 Gynecol. Oncol. 56: 39–44

  • Chambers SK, Ivins CM, Carcangiu ML . 1998 Int. J. Cancer 79: 449–454

  • Courjal F, Louason G, Speiser P, Katsaros D, Zeillinger R, Theillet C . 1996 Int. J. Cancer 69: 247–253

  • Crickard K, Niedbala MJ, Crickard U, Yoonessi M, Sandberg AA, Okuyama K, Bernacki RJ, Satchidanand SK . 1989 Gynecol. Oncol. 32: 163–173

  • DiSaia PJ, Morrow M, Kanabus J, Piechal W, Townsend DE . 1975 Gynecol. Oncol. 3: 215–219

  • Fogh J, Trempe G . 1975 New Human Tumor Cell Lines Plenum Press, New York

    Book  Google Scholar 

  • Golombick T, Bezwoda WR . 1991 Eur. J. Cell Biol. 56: 459–463

  • Golombick T, Dansey R, Bezwoda WR, Rosendorff J . 1990 In Vitro Cell Dev. Biol. 26: 447–454

  • Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES . 1999 Science 286: 531–537

  • Grunt TW, Oeller H, Somay C, Dittrich C . 1993 Differentiation 53: 45–50

  • Hamilton TC, Young RC, McKoy WM, Grotzinger KR, Green JA, Chu EW, Whang-Peng J, Rogan AM, Green WR, Ozols RF . 1983 Cancer Res. 43: 5379–5389

  • Hirte HW, Kaiser JS, Bacchetti S . 1994 Cancer 74: 900–906

  • Hudson TJ, Stein LD, Gerety SS, Ma J, Castle AB, Silva J, Slonim DK, Baptista R, Kruglyak L, Xu SH et al. 1995 Science 270: 1945–1954

  • Huleihel M, Maymon E, Piura B, Prinsloo I, Benharroch D, Yanai-Inbar I, Glezerman M . 1997 Eur. Cytokine Netw. 8: 179–187

  • Kruk PA, Maines-Bandiera SL, Auersperg N . 1990 Lab. Invest. 63: 132–136

  • Langdon SP, Lawrie SS, Hay FG, Hawkes MM, McDonald A, Hayward IP, Schol DJ, Hilgers J, Leonard RC, Smyth JF . 1988 Cancer Res. 48: 6166–6172

  • Lounis H, Provencher D, Godbout C, Fink D, Milot MJ, Mes-Masson AM . 1994 Exp. Cell Res. 215: 303–309

  • Mitelman F, Mertens F, Johansson B . 1997 Nat. Genet. 15: 417–474

  • Mok SC, Chan WY, Wong KK, Muto MG, Berkowitz RS . 1996 Oncogene 12: 1895–1901

  • Neyns B, Katesuwanasing Vermeij J, Bourgain C, Vandamme B, Amfo K, Lissens W, DeSutter P, Hooghe-Peters E, DeGreve J . 1996 Oncogene 12: 1247–1257

  • Ono K, Tanaka T, Tsunoda T, Kitahara O, Kihara C, Okamoto A, Ochiai K, Takagi T, Nakamura Y . 2000 Cancer Res. 60: 5007–5011

  • Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D . 2000 Nature 406: 747–752

  • Provencher DM, Finstad CL, Saigo PE, Rubin SC, Hoskins WJ, Federici MG, Stockert E, Lloyd KO, Lewis Jr JL . 1993 Gynecol. Oncol. 50: 78–83

  • Provencher DM, Lounis H, Champoux L, Tetrault M, Manderson EN, Wang JC, Eydoux P, Savoie R, Tonin PN, Mes-Masson AM . 2000 In Vitro Cell Dev. Biol. Anim. 36: 357–361

  • Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D . 1997 World Wide Web URLhttp://bioinfo.weizmann.ac.jl/cards

  • Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO . 2000 Nat. Genet. 24: 227–235

  • Saccone S, De Sario A, Della Valle G, Bernardi G . 1992 Proc. Natl. Acad. Sci. USA 89: 4913–4917

  • Sinna GA, Beckman G, Lundgren E, Nordenson I, Roos G . 1979 Gynecol. Oncol. 7: 267–280

  • St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW . 2000 Science 289: 1197–1202

  • Staudt LM . 2000 J. Exp. Med. 191: 207–212

  • Tamayo P, Slonim D, Mesirov J, Zhu Q, Kitareewan S, Dmitrovsky E, Lander ES, Golub TR . 1999 Proc. Natl. Acad. Sci. USA 96: 2907–2912

  • Tanner B, Hengstler JG, Luch A, Meinert R, Kreutz E, Arand M, Wilkens C, Hofmann M, Oesch F, Knapstein PG, Becker R . 1998 Int. J. Gynecol. Pathol. 17: 66–74

  • Wang K, Gan L, Jeffery E, Gayle M, Gown AM, Skelly M, Nelson PS, Ng WV, Schummer M, Hood L, Mulligan J . 1999 Gene 229: 101–108

  • Welsh B, Zarrinkar P, Sapinoso LM, Kern SG, Behling CA, Monk BJ, Lockhart DJ, Burger RA, Hampton GM . 2001 Proc. Natl. Acad. Sci. USA 98: 1176–1181

  • Wong WS, Wong YF, Ng YT, Huang PD, Chew EC, Ho TH, Chang MZ . 1990 Gynecol. Oncol. 38: 37–45

  • Woods LK, Morgan RT, Quinn LA, Moore GE, Semple TU, Stedman KE . 1979 Cancer Res. 39: 4449–4459

  • Wysocki SJ, Hahnel E, Masters A, Smith V, McCartney AJ, Hahnel R . 1990 Cancer Res. 50: 1800–1802

  • Yamada T, Ueda M, Otsuki Y, Ueki M, Sugimoto O . 1991 Gynecol. Oncol. 40: 118–128

Download references

Acknowledgements

We gratefully acknowledge the assistance of Todd Golub for microarray analysis. We thank L Champoux and F Dion for technical assistance. We are grateful to Dr P Drouin, P Gauthier and J Dubuc-Lissoir for clinical samples, Dr R Vauclair for pathology and N Belanger for clerical assistance with pathology reports. This research was supported by grants from the Medical Research Council of Canada (MRC) (to A-M Mes-Masson, PN Tonin, TJ Hudson and D Provencher), the Canadian Genetic Diseases Network, Federal Networks of Centres of Excellence Program (to TJ Hudson), and a research contract from Bristol-Myers Squibb, Millennium Pharmaceuticals Inc. and Affymetrix (TJ Hudson). M Bossolasco is the recipient of a studentship from the MRC; EN Manderson is the recipient of a studentship from the Natural Sciences and Engineering Research Council of Canada; M Bossolasco and F Rodier receive salary support from the Institut du cancer de Montréal through the Canderel and Foundation Bourgie initiatives; PN Tonin is scholar of the MRC and the Cancer Research Society, Inc; TJ Hudson is a recipient of a Clinician Scientist Award from the MRC; D Provencher is a recipient of a Chercheur-Cliniciens Senior from the Fonds de Recherche en Santé du Québec (FRSQ).; and A-M Mes-Masson is a recipient of a Chercheur National fellowship from the FRSQ.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anne-Marie Mes-Masson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tonin, P., Hudson, T., Rodier, F. et al. Microarray analysis of gene expression mirrors the biology of an ovarian cancer model. Oncogene 20, 6617–6626 (2001). https://doi.org/10.1038/sj.onc.1204804

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204804

Keywords

This article is cited by

Search

Quick links